Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Juan R. Luciano acquired 16 shares of Eli Lilly common stock through a deferral plan, as reported in a recent SEC filing.

Summary

• Director Juan R. Luciano acquired 16 shares of Eli Lilly common stock on August 19, 2024.
• The shares were acquired at a price of $921.81 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan.
• The shares will be settled in common stock following the director's separation from service.
• The transaction was reported on August 20, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it shows director alignment with the company's success. There is no indication of any negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the director's separation from service.

Industry Context

This is a routine transaction for a director of a public company, and it is common for directors to receive stock as part of their compensation.

Comparison to Industry Standards

• Director share acquisitions are a common practice across publicly traded companies.
• Deferral plans are also a standard method of compensation for directors, allowing them to defer income and potentially benefit from future stock appreciation.
• The price of $921.81 per share is consistent with the market price of Eli Lilly stock at the time of the transaction.

Stakeholder Impact

• The acquisition of shares by a director can be seen as a positive signal to shareholders.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, SEC Form 4, Stock Units, Juan R. Luciano